Namperumalsamy Venkatesh Prajna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Namperumalsamy Venkatesh Prajna has a total of 584 co-authors. Here are the top co-authors by number of shared publications:
Prajna Lalitha
Department of Ocular Microbiology, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India
37 shared publicationsMuthiah Srinivasan
Madurai, India
36 shared publicationsThomas M. Lietman
Francis I. Proctor Foundation, University of California San Francisco, San Francisco, California
22 shared publicationsJeena Mascarenhas
Department of Cornea and External Diseases, Aravind Eye Care System, Madurai, India
20 shared publicationsNisha R. Acharya
Department of Ophthalmology, University of California, San Francisco, San Francisco
20 shared publicationsStephen D. McLeod
Department of Ophthalmology, University of California, San Francisco, San Francisco
19 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Springer Nature in Eye
- p. 1-8
Multidrug antifungal resistance and clinical outcomes in fungal keratitis: a prospective study in a South Indian population
Objectives: Our primary objective was to identify the rate of antifungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May–August 2025) with culture-positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole minimum inhibitory concentration (MIC; n = 151–153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons. Patient disease outcome relative to isolate resistance was analysed by Fisher’s exact test ( n = 91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera ( P < 0.0001). Fusarium spp. isolates ( n = 81) resistant to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5%; and econazole: 76.5%. Aspergillus spp. isolates ( n = 33) resistant to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with an adverse clinical outcome, P = 0.0034, relative risk 1.7 (95% CI: 1.2–2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, and 28% were resistant to all of them. Resistance to natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus, even when susceptible to azoles. Our data support the need for species-specific MIC thresholds to have increased clinical utility.
- 1 October 2026
- Published by Springer Nature in Eye
- p. 1-8
Open AccessMultidrug antifungal resistance and clinical outcomes in fungal keratitis: a prospective study in a South Indian population
Objectives: Our primary objective was to identify the rate of antifungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May–August 2025) with culture-positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole minimum inhibitory concentration (MIC; n = 151–153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons. Patient disease outcome relative to isolate resistance was analysed by Fisher’s exact test ( n = 91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera ( P < 0.0001). Fusarium spp. isolates ( n = 81) resistant to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5%; and econazole: 76.5%. Aspergillus spp. isolates ( n = 33) resistant to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with an adverse clinical outcome, P = 0.0034, relative risk 1.7 (95% CI: 1.2–2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, and 28% were resistant to all of them. Resistance to natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus, even when susceptible to azoles. Our data support the need for species-specific MIC thresholds to have increased clinical utility.
- 3 August 2026
- Published by Wolters Kluwer Health in Cornea
Association of Clinical Measures and Characteristics of Microbial Keratitis with Patient-Reported Visual Function
Purpose: To investigate the association between clinical findings and vision-related quality of life in patients with microbial keratitis (MK) in the United States. Methods: Data from a prospective cohort of individuals with newly diagnosed MK were obtained at baseline and 90 days, including demographics, best-corrected visual acuity (BCVA), morphology, infection type, and the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). Spearman correlations (r s ) were used to assess associations between clinical measures and VFQ-25 scores; group differences were tested using Wilcoxon tests with Holm adjustment. Primary outcomes were 90-day VFQ-25 composite and subscale scores. Results: Seventy-nine participants (mean age: 53.6 ± 18.0 years, 47.4% male) completed the VFQ-25 with a mean composite score of 72.4 ± 23.1. Lower composite scores were associated with worse baseline affected-eye BCVA (r s = −0.44, P = 0.0027) and fluffy infiltrate (median 64.6 vs. 83.1, P = 0.018). At 90 days, lower scores were associated with worse affected-eye BCVA (r s = −0.68, P < 0.0001), worse better-eye BCVA (r s = −0.42, P = 0.006), persistent epithelial defect (36.1 vs. 83.1, P = 0.0098), persistent stromal infiltrate (42.0 vs. 83.1, P = 0.0240), and lack of healing (42.0 vs. 83.3, P < 0.0001). Worse 90-day affected-eye BCVA was associated with lower subscale scores for general vision, ocular pain, mental health, role difficulties, and driving (all P ≤ 0.0005). VFQ-25 scores did not differ by infection type ( P = 1.0000). Conclusions: Vision-related impairment in patients with MK is associated not only with BCVA but also with clinical markers of disease activity and healing, including persistent epithelial defect, stromal infiltrate, and nonhealed status. These findings suggest that functional impairment is related to factors beyond visual acuity.
- 3 August 2026
- Published by Wolters Kluwer Health in Cornea
Association of Clinical Measures and Characteristics of Microbial Keratitis with Patient-Reported Visual Function
Purpose: To investigate the association between clinical findings and vision-related quality of life in patients with microbial keratitis (MK) in the United States. Methods: Data from a prospective cohort of individuals with newly diagnosed MK were obtained at baseline and 90 days, including demographics, best-corrected visual acuity (BCVA), morphology, infection type, and the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). Spearman correlations (r s ) were used to assess associations between clinical measures and VFQ-25 scores; group differences were tested using Wilcoxon tests with Holm adjustment. Primary outcomes were 90-day VFQ-25 composite and subscale scores. Results: Seventy-nine participants (mean age: 53.6 ± 18.0 years, 47.4% male) completed the VFQ-25 with a mean composite score of 72.4 ± 23.1. Lower composite scores were associated with worse baseline affected-eye BCVA (r s = −0.44, P = 0.0027) and fluffy infiltrate (median 64.6 vs. 83.1, P = 0.018). At 90 days, lower scores were associated with worse affected-eye BCVA (r s = −0.68, P < 0.0001), worse better-eye BCVA (r s = −0.42, P = 0.006), persistent epithelial defect (36.1 vs. 83.1, P = 0.0098), persistent stromal infiltrate (42.0 vs. 83.1, P = 0.0240), and lack of healing (42.0 vs. 83.3, P < 0.0001). Worse 90-day affected-eye BCVA was associated with lower subscale scores for general vision, ocular pain, mental health, role difficulties, and driving (all P ≤ 0.0005). VFQ-25 scores did not differ by infection type ( P = 1.0000). Conclusions: Vision-related impairment in patients with MK is associated not only with BCVA but also with clinical markers of disease activity and healing, including persistent epithelial defect, stromal infiltrate, and nonhealed status. These findings suggest that functional impairment is related to factors beyond visual acuity.
- Open Access
Multidrug Antifungal Resistance and Clinical Outcomes in Fungal Keratitis: A Prospective Study in a South Indian Population
Objectives: Our primary objective was to identify the rate of anti-fungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/Methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May – August 2025) with culture positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole MIC (n=151-153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Patient disease outcome relative to isolate resistance was analysed by fisher’s exact test (n=91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera (PFusarium spp. isolates (n= 81) to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5% and econazole: 76.5%. Resistance of Aspergillus spp. isolates (n=33) to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with a poor clinical outcome, P=0.0034, relative risk 1.7 (95% CI: 1.2-2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, 15% were resistant to all of them. Resistance towards natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus , even when susceptible to azoles. Our data supports the need for species specific MIC thresholds to have increased clinical utility.
Open AccessMultidrug Antifungal Resistance and Clinical Outcomes in Fungal Keratitis: A Prospective Study in a South Indian Population
Objectives: Our primary objective was to identify the rate of anti-fungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/Methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May – August 2025) with culture positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole MIC (n=151-153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Patient disease outcome relative to isolate resistance was analysed by fisher’s exact test (n=91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera (PFusarium spp. isolates (n= 81) to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5% and econazole: 76.5%. Resistance of Aspergillus spp. isolates (n=33) to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with a poor clinical outcome, P=0.0034, relative risk 1.7 (95% CI: 1.2-2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, 15% were resistant to all of them. Resistance towards natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus , even when susceptible to azoles. Our data supports the need for species specific MIC thresholds to have increased clinical utility.
- Open Access
- 21 January 2026
- Published by Springer Nature in Eye
- Vol. 40 (4) , 449-450
Allied Ophthalmic Personnel: Backbone of Aravind’s Eye Care and Social Mission
- 21 January 2026
- Published by Springer Nature in Eye
- Vol. 40 (4) , 449-450
Open AccessAllied Ophthalmic Personnel: Backbone of Aravind’s Eye Care and Social Mission
- Open Access
Trends in aetiology and antibiotic resistance in bacterial keratitis isolates from South India between 2013-2024
Aim: To measure aetiology and antibiotic resistance (AMR) trends of bacteria cultured from corneal scrapings from patients with infectious keratitis at a tertiary referral hospital in South India. Methods: In this retrospective study, bacterial aetiology and antimicrobial resistance profiles were identified from the microbiology records of patients undergoing microbial keratitis diagnosis at the Aravind Eye Hospital, Madurai, India from 2013-2024. Statistical analyses were performed by Spearman’s rank correlation coefficient to identify significant trends. Results: P. aeruginosa (n=1047) was the most frequently isolated bacteria, followed by S. pneumoniae (n=987). There were significant increases in the number of P. aeruginosa (rs: 0.66; P=0.0219) and S. aureus isolates cultured (r s : 0.70; P=0.0130). S. aureus demonstrated increasing resistance to cefazolin (rs: 0.76; P=0.0015), gatifloxacin (rs: 0.75; P=0.0071), levofloxacin (r s : 0.60; P=0.0442), moxifloxacin (r s : 0.59; P=0.0437) and chloramphenicol (r s : 0.78; P=0.0049) over time. S. pneumoniae resistance towards tetracycline significantly increased (r s : 0.80; P=0.0029). P. aeruginosa isolates remained largely susceptible to all antibiotics screened, with significant decreasing resistance rates to ceftazidime (r s : −0.71; P=0.019), amikacin (r s : −0.59; P=0.0489), gentamicin (r s : −0.66; P=0.0219) and tobramycin (r s : −0.69; P=0.017) identified. No significant trends in resistance patterns were identified for Nocardia spp .. Conclusion: Bacterial aetiology and antibiotic resistance rates shifted over time for key pathogens causing keratitis. Understanding these in the local context is important. For instance, while others in India have reported increasing P. aeruginosa AMR, we did not find this to be true in our patient population. This may have implications for local prescribing guidelines. Key Messages: What is already known on this topic: Microbial keratitis remains a highly prevalent, sight-limiting condition in India. Treatment options are limited, and are confounded by emergent antibiotic resistance (AMR) of causative pathogens. What this study adds: This study demonstrates shifting bacterial aetiology, and antimicrobial resistance patterns. Our data on P. aeruginosa resistance patterns contradict other reporting within India, where our resistance rates remained low. How this study might affect research, practice or policy: Fluoroquinolones are the most common first-line treatment for bacterial keratitis, yet over 80% of our S. aureus isolates demonstrated resistance towards fluoroquinolones in 2024. Understanding local and temporal bacterial aetiology and resistance rates are imperative for designing local guidelines for patient treatment practices.
Open AccessTrends in aetiology and antibiotic resistance in bacterial keratitis isolates from South India between 2013-2024
Aim: To measure aetiology and antibiotic resistance (AMR) trends of bacteria cultured from corneal scrapings from patients with infectious keratitis at a tertiary referral hospital in South India. Methods: In this retrospective study, bacterial aetiology and antimicrobial resistance profiles were identified from the microbiology records of patients undergoing microbial keratitis diagnosis at the Aravind Eye Hospital, Madurai, India from 2013-2024. Statistical analyses were performed by Spearman’s rank correlation coefficient to identify significant trends. Results: P. aeruginosa (n=1047) was the most frequently isolated bacteria, followed by S. pneumoniae (n=987). There were significant increases in the number of P. aeruginosa (rs: 0.66; P=0.0219) and S. aureus isolates cultured (r s : 0.70; P=0.0130). S. aureus demonstrated increasing resistance to cefazolin (rs: 0.76; P=0.0015), gatifloxacin (rs: 0.75; P=0.0071), levofloxacin (r s : 0.60; P=0.0442), moxifloxacin (r s : 0.59; P=0.0437) and chloramphenicol (r s : 0.78; P=0.0049) over time. S. pneumoniae resistance towards tetracycline significantly increased (r s : 0.80; P=0.0029). P. aeruginosa isolates remained largely susceptible to all antibiotics screened, with significant decreasing resistance rates to ceftazidime (r s : −0.71; P=0.019), amikacin (r s : −0.59; P=0.0489), gentamicin (r s : −0.66; P=0.0219) and tobramycin (r s : −0.69; P=0.017) identified. No significant trends in resistance patterns were identified for Nocardia spp .. Conclusion: Bacterial aetiology and antibiotic resistance rates shifted over time for key pathogens causing keratitis. Understanding these in the local context is important. For instance, while others in India have reported increasing P. aeruginosa AMR, we did not find this to be true in our patient population. This may have implications for local prescribing guidelines. Key Messages: What is already known on this topic: Microbial keratitis remains a highly prevalent, sight-limiting condition in India. Treatment options are limited, and are confounded by emergent antibiotic resistance (AMR) of causative pathogens. What this study adds: This study demonstrates shifting bacterial aetiology, and antimicrobial resistance patterns. Our data on P. aeruginosa resistance patterns contradict other reporting within India, where our resistance rates remained low. How this study might affect research, practice or policy: Fluoroquinolones are the most common first-line treatment for bacterial keratitis, yet over 80% of our S. aureus isolates demonstrated resistance towards fluoroquinolones in 2024. Understanding local and temporal bacterial aetiology and resistance rates are imperative for designing local guidelines for patient treatment practices.
- 2 September 2025
- Published by Elsevier in Ophthalmology
- Vol. 133 (2) , 161-168
Rose Bengal Electromagnetic Activation with Green Light for Infection Reduction Study
- 2 September 2025
- Published by Elsevier in Ophthalmology
- Vol. 133 (2) , 161-168
Rose Bengal Electromagnetic Activation with Green Light for Infection Reduction Study
- Open Access
- 3 February 2025
- Published by Wolters Kluwer Health in Cornea
- Vol. 44 (7) , 921-924
Clinical Utility of CRISPR-Based RID-MyC Assay in Smear and Culture-Negative Fungal Keratitis: A Case Series
Purpose: To assess the clinical utility of the clustered regularly interspaced short palindromic repeats/Cas12a-based RID-MyC assay in diagnosing fungal keratitis (FK) in cases where conventional smear and culture methods fail to identify the causative pathogen. Methods: This retrospective case series included 5 patients with clinically suspected FK and negative smear and culture results who were evaluated in the Cornea Department at Aravind Eye Hospital, Coimbatore, India, between January 1, 2024, and March 31, 2024. The primary outcome was the diagnostic performance of the RID-MyC assay in detecting fungal nucleic acids in cases of suspected FK with negative smear and culture results. In vivo confocal microscopy served as a reference standard to validate the RID-MyC assay findings. Results: The RID-MyC assay successfully detected fungal nucleic acids in 3 cases, corroborated by in vivo confocal microscopy findings suggestive of fungal filaments, leading to targeted antifungal therapy and resolution of the infections. In addition, 2 cases tested negative for fungal nucleic acids, aligning with clinical and confocal evidence of nonfungal etiology, thus guiding appropriate alternative treatments that led to clinical improvement. Conclusions: The RID-MyC assay demonstrates clinical utility in diagnosing FK in scenarios where conventional smear and culture methods prove inadequate, such as in cases with prior antifungal therapy or polymicrobial infections. This assay facilitates accurate diagnosis and timely initiation of appropriate antifungal treatment without the need for sophisticated equipment or expertise, making it particularly valuable in resource-limited settings.
- 3 February 2025
- Published by Wolters Kluwer Health in Cornea
- Vol. 44 (7) , 921-924
Open AccessClinical Utility of CRISPR-Based RID-MyC Assay in Smear and Culture-Negative Fungal Keratitis: A Case Series
Purpose: To assess the clinical utility of the clustered regularly interspaced short palindromic repeats/Cas12a-based RID-MyC assay in diagnosing fungal keratitis (FK) in cases where conventional smear and culture methods fail to identify the causative pathogen. Methods: This retrospective case series included 5 patients with clinically suspected FK and negative smear and culture results who were evaluated in the Cornea Department at Aravind Eye Hospital, Coimbatore, India, between January 1, 2024, and March 31, 2024. The primary outcome was the diagnostic performance of the RID-MyC assay in detecting fungal nucleic acids in cases of suspected FK with negative smear and culture results. In vivo confocal microscopy served as a reference standard to validate the RID-MyC assay findings. Results: The RID-MyC assay successfully detected fungal nucleic acids in 3 cases, corroborated by in vivo confocal microscopy findings suggestive of fungal filaments, leading to targeted antifungal therapy and resolution of the infections. In addition, 2 cases tested negative for fungal nucleic acids, aligning with clinical and confocal evidence of nonfungal etiology, thus guiding appropriate alternative treatments that led to clinical improvement. Conclusions: The RID-MyC assay demonstrates clinical utility in diagnosing FK in scenarios where conventional smear and culture methods prove inadequate, such as in cases with prior antifungal therapy or polymicrobial infections. This assay facilitates accurate diagnosis and timely initiation of appropriate antifungal treatment without the need for sophisticated equipment or expertise, making it particularly valuable in resource-limited settings.
- Open Access
- 29 November 2024
- Published by Elsevier in Ophthalmology Science
- Vol. 5 (2) , 100665
Multimodal Deep Learning for Differentiating Bacterial and Fungal Keratitis Using Prospective Representative Data
- 29 November 2024
- Published by Elsevier in Ophthalmology Science
- Vol. 5 (2) , 100665
Open AccessMultimodal Deep Learning for Differentiating Bacterial and Fungal Keratitis Using Prospective Representative Data
- 1 March 2024
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 142 (3) , 241-242
Prevention in the Management of Infectious Keratitis
The morbidity associated with infectious keratitis (IK) has been increasingly recognized globally, especially among developing countries. International corneal
- 1 March 2024
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 142 (3) , 241-242
Prevention in the Management of Infectious Keratitis
The morbidity associated with infectious keratitis (IK) has been increasingly recognized globally, especially among developing countries. International corneal
- Open Access
- 1 October 2023
- Published by Wolters Kluwer Health in TNOA Journal of Ophthalmic Science and Research
- Vol. 61 (4) , 382-385
Changing Paradigm in Diagnosing Infectious Keratitis
- 1 October 2023
- Published by Wolters Kluwer Health in TNOA Journal of Ophthalmic Science and Research
- Vol. 61 (4) , 382-385
Open AccessChanging Paradigm in Diagnosing Infectious Keratitis